SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as natural gas prices sharply reverse, primarily driven by dramatically warmer weather forecasts that are erasing previous cold-snap gains. The community is actively discussing the extreme volatility and "widow maker" nature of natural gas ETFs, with many attempting to capitalize on KOLD's rapid ascent amidst widespread price uncertainty. This significant shift in winter weather expectations is compelling traders to adjust positions, leading to rapid price movements in inverse natural gas products.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Jackson highlighted the rising origination, new capital flow, and the tailwinds that are helping the firm propel forward.</li><li>He stated that the company is well-positioned to address any uncertainties arising from the current environment.</li><li>The CEO noted that, given the company's efficiency and profitability, raising the guidance was a natural outcome.</li></ul>Abacus Global Management Inc. (ABL) recently reported an upbeat third quarter, with the results surpassing Wall Street expectations for the tenth consecutive quarter.Abacus Global reported earnings per share (EPS) of $0.24 in the third quarter (Q3), compared to an estimated EPS of $0.18, according to Stocktwits data. Its revenue stood at $63 million during the quarter, compared to a Street estimate of $50.2 million.<a href="https://stocktwits.com/symbol/ABL">Abacus Global shares</a> were up more than 4% in Monday’s opening trade. Retail sentiment on Stocktwits around the company trended in the ‘extremely bullish’ territory at the time of writing.Stocktwits caught up with CEO Jay Jackson to understand what drove Abacus Global’s Q3 performance, and what lies ahead for the company.We would like to start with your thoughts on Q3 performance, as well as the longevity of the product in the Middle East.We had an incredibly productive Q3. That was our 10th consecutive quarter in a row where we had exceeded earnings expectations related to consensus. So, we're incredibly proud of that. What's interesting about that statistic is that, actually, six of those quarters we beat earnings estimates by over 30%, including Q3, primarily driven by our continued efforts to expand our message and reach new investors and policyholders.We're seeing our origination tick up. We're also seeing new capital coming into the asset. But most importantly, from a market perspective, I think we've also got some wind at our backs. Specifically, around the premise that people are seeking uncorrelated assets. There's almost a flight to safety and other kinds of assets. And this is an uncorrelated yielding product. And now we're starting to see investors really lean into this asset class. I think that's also helping drive our success right now. And we foresee this continuing.The company's business is evolving slightly from a niche life settlement player to the broader alternative asset management and wealth management segments. What’s driving this transformation?I think that was always kind of the natural evolution of our company, which is that we provide a very distinct service initially to policyholders, and that service is helping them monetize or understand the liquidity in their life insurance policy through its current market value.If the number one fear in retirement is running out of money, wouldn't you like to know how long you're going to be in retirement? Right? So, our underwriting is being applied in multiple ways. But in addition to that, institutional asset management firms, banks, etc., have been looking for this kind of yield.How do you plan to sustain this momentum?One, there's a huge amount of excitement around investing in uncorrelated assets. Just look at the price of gold. Gold's what, $4,000 now, right? You could look at alternative assets, whether it's private credit, [they’ve] raised billions. So I think that there's a lot of room to go here, and quite frankly, we're just scratching the surface. Our expectation is that there will be billions and billions of dollars in assets under management with our firm.We expect people to continue seeking this kind of asset, and don't forget that we're the originator. We're the market maker of that asset. So, they have to come to us, and now they're investing directly.Amid this evolution, the company announced a dividend and share buyback. How do you strike a balance between distributing capital and reinvesting in the company's future growth?We felt it was the right time, and the reason was that as we've seen our business evolve, we wanted to reward our shareholders appropriately. If you look at the formula that we put out in our press release, we actually put out a pretty conservative dividend. It's only a little over 20% of our adjusted net income.We have excess capital to deploy, and we took that excess capital and capitalized our shareholders through our recurring revenues. We think that's the right way to conduct ourselves as an alternative asset manager and should be rewarding our shareholders on an annual basis.Regarding the disconnect in valuation, what do you think retail investors and institutions are missing out on?It’s really an education issue, and it's not just institutions; it's retail, it's across the board in understanding that first and foremost, life insurance is an asset. People treat it as something that they never want to use or as a piece of debt. They don't see it, oh, this is just like any other form of private credit. And so that's why that disconnect exists.That education has to start at the core level, and that takes time. We've spent the last three years doing that, and that message is really starting to resonate.We're right at the precipice of what I think is a breakout. And it's coming from institutions, which are really starting to get this business, retail investors who are kind of nodding their heads and saying, "Oh, I really do get this now."What was the driving factor behind raising FY25 net income guidance?I would say the driving factor for us continuing to increase our guidance is predominantly driven by market forces, in a sense. We are [also] becoming more efficient in our underlying business.We run an incredibly efficient and profitable business. And so I think when you look at the raise on our guidance, that was a natural outcome.The average realized gain in Q3 was around 37%, up from 26% in Q2. Is this due to efficiency, or is there another factor driving it? Do you think this is sustainable?I think it's definitely driven by efficiency, but you'll see it vary quarter to quarter. I mean, if you go back a few more quarters, you'll see that number hover between the 20% to 25% range. And I think that this was an exceptional quarter in Q3, partly driven by our efficiencies, partly driven by market factors.There's a lot of uncertainty regarding rates, and people are still not sure if there will be a hard landing or a recession. How are you going to tackle this sort of uncertainty going forward?We're in a great spot for that kind of uncertainty. I mean, consider the asset. We would benefit in two ways. Actually, both sides of our transaction.One, if you're a policyholder and we're in a recession, and you're seeking liquidity, which means you'll look to places that you may not have considered in the past, such as your life insurance policy, to seek liquidity where you haven't done so before. Originations will more than likely tick up during a recession.The second piece that investors seek during a recessionary environment, like a volatile market or a pullback, is uncorrelated assets.What makes you distinct from your competitors, and can you explain the competitive advantage you have?We're the only public company in our entire industry, and that gives us a significant advantage from both a cost of capital and an efficiency perspective. You know we're always driving our growth, because as a public company, you know you're reporting every quarter, and so being innovative is super important.The interview has been edited for clarity and length.<a href="https://stocktwits.com/symbol/ABL">ABL stock</a> is down 18% year-to-date and 27% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-rise-senate-votes-to-end-government-shutdown/cLPcKrVRE22">Dow Futures Rise As Senate Votes To End Government Shutdown: MTSR, VSAT, RUM, TSM Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retirement planning representational image

Exclusive: Abacus Global CEO Jay Jackson Eyes Billions In AUM, Explains How The Company Plans To Bridge The Valuation Disconnect

In an exclusive conversation with Stocktwits, Jackson lays out what drove Abacus Global’s performance, the market opportunity ahead, and what makes the company distinct from its competitors.

ABLD
Abacus FCF ETF Trust - Abacus FCF Real Assets Leaders ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ABLD News

ABLDAbacus FCF ETF Trust - Abacus FCF Real Assets Leaders ETF